Real-World Reassurance on Bleeding Risk With DOACs in VTE Real-World Reassurance on Bleeding Risk With DOACs in VTE

A new observational study found that the new direct oral anticoagulants are not associated with increased risk for major bleeding or all-cause mortality compared with warfarin in the first 3 months of treatment.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news